advertising

Comedian Jim Carrey urges people to delete their Facebook accounts and dump the stock

Jim Carrey is quitting Facebook and dumping his stock — and is urging everyone else to do so as well.

“We must encourage more oversight by the owners of these social media platforms,” Jim Carrey said in a statement to CNBC. “This easy access has to be more responsibly handled. What we need now are activist investors to send a message that responsible oversight is needed. What the world needs now is capitalism with a conscience.”

The comedian tweeted on Tuesday he was selling his Facebook shares and deleting his page because the company profited from Russian interference during the 2016 U.S. election. He asked all “other investors who care about our future to do the same.” Carrey did not state how many Facebook shares he owned or sold.

He added the hashtag “#unfriendfacebook.”

But what about those of us that use the platform to become noticed, to make it big, to earn a living?

blackmattersus:

It is shockingly racist: The video, which you can watch above, shows a fetching Chinese woman lure a paint-stained, lascivious African man toward her. She briefly toys with him before shoving a detergent capsule into his mouth and him into the machine. Out emerges a fresh-faced Chinese man, looking sparkling white and clean.

America Taught China and India racism towards black people.

Click for more From BlackMattersUs

And Europe gave many lessons as well

ahfspeakout:

AHF is currently running a TV ad targeting Gilead Sciences for the high drug prices it charges cash-strapped AIDS Drug Assistance Programs (ADAP).

Gilead is the focal point of this ad for obvious reasons – its high prices have left thousands of people without access to lifesaving AIDS treatment. However, they’re not the only drug company gouging ADAP, so why Gilead and why now? Simply put, because Gilead sells more drugs to ADAP than any other company, with Atripla alone accounting for nearly 20% of all ADAP expenditures.

With such a dominant share of ADAP resources, moderate price reductions from Gilead would help generate the savings these programs desperately need. Moreover, given the struggling economy, and the intense pressure on states and Congress to cut spending – not increase it – these reductions are the only way to end the ADAP crisis.

Thankfully for Gilead, this will have no impact on their profits from ADAP, as the cost savings will be used to buy more drugs.

For more information on AHF’s advocacy for lower pricing from Gilead and all the AIDS drug companies, please visit saveadap.org.